Supplementary Figure S3 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

David J. Pinato; Antonio D’Alessio; Claudia Angela Maria Fulgenzi; Alexandra Emilia Schlaak; Ciro Celsa; Saskia Killmer; Jesús Miguéns Blanco; Caroline Ward; Charalampos‐Vlasios Stikas; Mark R. Openshaw; Nicole Acuti; Georgios Nteliopoulos; Cristina Balcells; Hector C. Keun; Robert Goldin; Paul J. Ross; Alessio Cortellini; Robert Thomas; Anna-Mary Young; Nathan Danckert; Paul Tait; Julian R. Marchesi; Bertram Bengsch; Rohini Sharma

doi:10.1158/1078-0432.25956643.v1

Abstract

Supplementary Figure S3. Manual gating scheme used for analysis of peripheral immune landscape. Live singlet CD45+ were gated on CD3+CD19- and CD3-CD19+ cells. T cells were further gated on CD4 T cells, CD8 T cells, MAIT cells, gd T cells and NKT cells.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pinato et al. (2024) studied this question.

synapsesocial.com/papers/68e6672fb6db6435875f3a91 https://doi.org/10.1158/1078-0432.25956643.v1

View Full Paper

Ask AI

Bookmark

Share

Supplementary Figure S3 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

Abstract

Discussion

Cite This Study

Supplementary Figure S3 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

Abstract

Discussion

Cite This Study

Keep reading

Keep reading